AUROPHARMA Intraday Analysis...
75% Offer Free Offer!!!!! Save Rs 9000/- (75% off) & Get Rs 3000/- Trading fee Bonus on Real Time Intraday Charts Register Now.

AUROPHARMA Share Price

Open 720.00 Change Price %
High 739.60 1 Day 6.00 0.83
Low 715.20 1 Week -21.15 -2.81
Close 731.15 1 Month -672.15 -47.90
Volume 1411115 1 Year 53.25 7.86
52 Week High 1535.00
52 Week Low 658.30
AUROPHARMA Important Levels
Resistance 2 753.77
Resistance 1 744.45
Pivot 728.65
Support 1 717.85
Support 2 708.53
AUROPHARMA CURRENT MONTH FUTURE
Close 730.45
Contracts Traded 12441
Open Intrest 3898500
Change In O.I -2990500
Lot Size 500
AUROPHARMA CURRENT MONTH OPTION
Most Active Call 750
Most Active put 725
Highest O.I Buildup Call 750
Highest O.I Buildup Put 700
Expiry Date 30-Jul-2015
AUROPHARMA ALL MONTHS OPTIONS
For All AUROPHARMA Options Click Here
NSE INDIA Most Active Stocks
NIFTY 8375.05 0.46%
UNITECH 6.25 -3.85%
KGL 4.10 -8.89%
KGL 4.10 -8.89%
KGL 4.10 -8.89%
JPASSOCIAT 8.85 -5.35%
ASHOKLEY 84.90 1.92%
SUZLON 21.30 2.90%
DLF 101.55 6.45%
ICICIBANK 289.25 1.49%
More..
NSE INDIA Top Gainers Stocks
VISESHINFO 0.10 100.00%
RASOYPR 0.25 25.00%
FARMAXIND 0.25 25.00%
SUMMITSEC 355.40 19.99%
ORIENTBELL 181.90 19.99%
PIRPHYTO 50.45 19.98%
NBVENTURES 169.65 19.98%
STARPAPER 35.15 19.97%
ARCHIDPLY 54.10 19.96%
NIBL 71.85 19.95%
More..
NSE INDIA Top Losers Stocks
ANTGRAPHIC 0.10 -33.33%
PARASPETRO 0.20 -20.00%
AUSTRAL 0.50 -16.67%
KSERASERA 0.25 -16.67%
VAIBHAVGBL 402.85 -14.10%
UMESLTD 2.65 -11.67%
MVL 0.40 -11.11%
MVL 0.40 -11.11%
BILENERGY 0.80 -11.11%
GULFOILLUB 488.45 -10.99%
More..

Aurobindo Pharma Limited (NSE: AUROPHARMA)

AUROPHARMA Technical Analysis 5
As on 29th Jul 2015 AUROPHARMA Share Price closed @ 731.15 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1135.04 & Strong Sell for SHORT-TERM with Stoploss of 1289.69 we also expect STOCK to react on Following IMPORTANT LEVELS.
AUROPHARMA Target for July
1st Target up-side 1573.37
2nd Target up-side 1658.44
3rd Target up-side 1743.51
1st Target down-side 1330.63
2nd Target down-side 1245.56
3rd Target down-side 1160.49
AUROPHARMA Synopsis Technicals View
50 Day EMA Close is Above EMA 50 (Short Term)
Bullish
100 Day EMA Close is Above EMA 100 (Mid Term) Bullish
200 Day EMA Close is Above EMA 200 (Long Term) Bullish
MACD (12 26 9) MACD Line is Grater Then SIGNAL Line Bullish
RSI (14) RSI is 68.32 Sideways
MFI (14) MFI is 54.52 Sideways
CCI (20) CCI is -13.16 Sideways
WILLIAM %R (14) William %R is -42.53 Sideways
ADX (14) ADX is Above 20 & +DI is Above -DI Up Trend
PSAR Stoploss For Long Buy 658.30
10 Day Avg Volume Traded 16.95 % More then 10 Day Average Volume
AUROPHARMA Other Details
Segment EQ
Market Capital 25150871552.00
Sector Pharmaceuticals
Industry
Offical website
AUROPHARMA Address
AUROPHARMA
N/A
AUROPHARMA Latest News
Interactive Technical Analysis Chart Aurobindo Pharma Limited ( AUROPHARMA NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Aurobindo Pharma Limited
AUROPHARMA Business Profile
Aurobindo Pharm is in the Pharmaceuticals sector. Founded in 1986 by Mr. P.V. Ramaprasad Reddy, Mr. K. Nityananda Reddy and a small group of highly committed professionals, Aurobindo Pharma was born off a vision. The company commenced operations in 1988-89 with a single unit manufacturing Semi-Synthetic Penicillin (SSP) at Pondicherry. Aurobindo Pharma became a public company in 1992 and listed its shares in the Indian stock exchanges in 1995. In addition to being the market leader in Semi-Synthetic Penicillins, it has a presence in key therapeutic segments such as neurosciences, cardiovascular, anti-retrovirals, anti-diabetics, gastroenterology and cephalosporins, among others. Aurobindo makes use of in-house R&D for rapid filing of patents, Drug Master Files (DMFs), Abbreviated New Drug Applications (ANDAs) and formulation dossiers across the world. Aurobindo Pharma is among the largest filers of DMFs and ANDAs from India. The current market capitalisation stands at Rs 8,284.96 crore.The company has reported a consolidated sales of Rs 1913.86 crore and a Net Profit of Rs 233.86 crore for the quarter ended Sep 2013. The company management includes K Ragunathan - Non Executive Chairman, K Nithyananda Reddy - Vice Chairman & Whole Time Dir, N Govindarajan - Managing Director, M Sivakumaran - Whole Time Director, M Madan Mohan Reddy - Whole Time Director, P V Ramprasad Reddy - Non Executive Director, P Sarath Chandra Reddy - Non Executive Director, M Sitarama Murthy - Non Executive Director, D Rajagopala Reddy - Non Executive Director, C Channa Reddy - Non Executive Director. It is listed on the BSE with a BSE Code of 524804 and the NSE with an NSE Code of AUROPHARMA. Its Registered office is at Plot No. 2, Maitrivihar,,Ameerpet Hyderabad,Andhra Pradesh - 500038.